Definitive Contract FA865621C0013
Award Date 7/6/21
Potential Completion Date 3/31/23
Potential Value $35M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boulder, CO 80303, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, is for the development and delivery of a high-performance point-of-care antibody test to assess immunity to the SARS-CoV-2 virus and confirm positive antibody tests. The $275,000 Firm Fixed Price contract was awarded on June 17, 2020 by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services. This contract was not set aside...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, for the development of a "Point of Care Host-Pathogen Monitoring System." The fixed-price contract has a ceiling value of $149,503.39 and was awarded on November 18, 2016, with a completion date of November 27, 2017. Mbio Diagnostics Inc. is a for-profit organization that develops...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order contract to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, for the "Rapid Detection of Legionella in Environmental Samples with Speciation and Serotyping." The contract, valued at $149,900.00, was set aside for a small business. Mbio Diagnostics Inc. is a company that develops diagnostic tests and devices, including rapid point-of-care tests,...
- This is a federal contract award from the Department of the Air Force Acquisition COVID-19 Task Force (DAF ACT) to Princeton Biomeditech Corp, doing business as P B M, for $9,885,816.00. The contract supports COVID-19 industrial base expansion efforts, including the development, production, and delivery of coronavirus diagnostics such as rapid, point-of-care tests, multiplex COVID-19 and influenza assays, and test readers. The contract is a definitive, firm-fixed-price contract with a completion...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $8,160 fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for Cepheid to provide its "EUA XPERT XPRESS SARS-COV-2/FLU/RSV+" diagnostic test, which can detect COVID-19, influenza, and respiratory syncytial virus. The contract has a completion date of March 26, 2024. Cepheid is the prime contractor, and there is no set-aside designation mentioned....
- This contract was awarded by the U.S. Department of the Air Force Air Education and Training Command to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract, valued at $160,500.00, is for the provision of COVID-19 testing products and services under a Delivery Order against Biofire's GSA Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a completion date of...
- This is a firm fixed-price BPA call order awarded by the U.S. Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base to Roche Diagnostics Corporation. The contract is for the provision of the Roche MICRO AUTOMATED MOLECULAR TESTING PLATFORM, including test kits and reagents, to support COVID-19 testing at the U.S. Air Force School of Aerospace Medicine (USAFSAM) Epidemiology Laboratory. The contract has a total ceiling value of $66,071.80 and a completion date of...
- The U.S. government has awarded a $3,400.00 Firm Fixed Price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, with a period of performance through December 13, 2024, was awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense. The contract is for the provision of XPCOV2/FLU/RSV-10 diagnostic test kits, which are used to...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $20,400.00 fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The contract is for Cepheid's "EUA XPERT XPRESS SARS-COV-2/FLU/RSV+" diagnostic test and is set to be completed by March 22, 2024. Cepheid has existing indefinite delivery contracts with the Department of Veterans Affairs and Department of the Army Medical...
- This is a Firm Fixed Price contract awarded by the Department of the Air Force's Air Force Life Cycle Management Center (AFLCMC) to Roche Diagnostics Corporation for the provision of COVID-19 Roche micro automated molecular testing platform, including kits and reagents, for the U.S. Air Force School of Aerospace Medicine (USAFSAM) Epidemiology Laboratory. The contract has a ceiling value of $81,020 and a completion date of May 13, 2020. It was awarded under Roche's existing General Services...
The U.S. Air Force awarded a $35,089,000 firm-fixed-price contract to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, to scale up manufacturing capacity for ultra-rapid point-of-care COVID-19 tests. The contract, which has a completion date of March 31, 2023, does not have a set-aside designation. Mbio Diagnostics is a company that develops diagnostic tests and devices, including rapid point-of-care tests, using its proprietary Lightdeck platform technology. Through past prime federal contract awards, the company has provided a variety of goods and services related to diagnostic test development, manufacturing, and distribution, primarily focused on supporting the coronavirus/COVID-19 response.
Generated 4/23/25, 12:07 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Supplemental Agreement for work within scope | $0 | 12/1/22 | |
| P00004 | Change Order | $0 | 3/9/22 | |
| P00003 | Change Order | $0 | 11/3/21 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 9/1/21 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 8/16/21 |